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Abstract— Pathological tremor is the most prevalent move-
ment disorder. In spite of the existence of various treatments
for it, tremor poses a functional problem to a large proportion
of patients. This paper presents the design and implemen-
tation of a novel neuroprosthesis for tremor management.
The paper starts by reviewing a series of design criteria that
were established after analyzing users needs and the expected
functionality of the system. Then, it summarizes the design of
the neuroprosthesis, which was built to meet the criteria defined
previously. Experimental results with a representative group of
12 patients show that the neuroprosthesis provided significant (p
< 0.001) and systematic tremor attenuation (in average 52.33 ±
25.48 %), and encourage its functional evaluation as a potential
new treatment for tremor in a large cohort of patients.
I. INTRODUCTION
Pathological tremor is the most prevalent movement dis-
order, affecting ∼ 15 % of people over 50 years according to
some estimates [1]. It appears due to a number of syndromes
yet not understood (see [2] for a review), being essential
tremor (ET) and Parkinson’s disease (PD) the most prevalent
among them. Tremor is currently treated through drugs or
neurosurgery, but unfortunately, it is not managed effectively
in ∼25 % of the patients [3]. Thus, it constitutes a major
cause of loss of independence and quality of life for many.
A number of alternative approaches for tremor manage-
ment are reported in the literature (see [4] for a review).
Among them, those devices based on the application of
forces to the tremulous limbs show a considerable potential.
These systems commonly rely on dissipative viscous ele-
ments (in a few cases combined with springs) to attenuate
the tremor [5]–[13]. The rationale for this is that viscous
elements exert a force that is proportional to velocity, and
tremors are faster than volitional movements [14], therefore
clinical and functional benefit should be, and in many cases
is, obtained. The group of patients enrolled in the previous
studies comprised the major tremor syndromes, except for
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PD, likely because these patients do not always exhibit
intention tremor. From a design perspective, these systems
span manipulanda [5], [6], [11], [15] and orthoses [7]–
[10], [12], [13]. Orthoses may be classified, according to
their implementation, as table-mounted [5]–[7], [11], [15],
wheelchair-mounted [8], [15], or ambulatory-aimed devices
[10], [12], [13]. The latter constitute the aim of our work,
given that they have the highest potential to impact during
the performance of activities of daily living (ADL).
An analysis of the drawbacks of ambulatory orthoses
incorporating mechanical actuators yielded that soft tissues
impede the efficient transmission of low forces to the mus-
culoskeletal system, which hampers the implementation of
solutions of this type [16]. Further, these type of orthoses
are bulky, and thus not positively perceived by users [13].
This paper presents the design and validation of a neuro-
prosthesis (NP) for tremor management. The NP uses tran-
scutaneous neurostimulation to compensate for the tremor,
thus avoiding the need of external actuators. The system is
conceived as a textile substrate that incorporates its main
components, maximizing usability. The rationale for the
application of force loads is the continuous modulation of
muscle co-contraction according to the characteristics of
the tremor. The results here presented provide evidence of
clinical benefit, and encourage a large scale validation.
Partial results have been previously published in [17], [18].
II. DESIGN OF THE NEUROPROSTHESIS
This section presents the design criteria established for
the cognitive and physical human-robot interfaces (cHRI and
pHRI, respectively) of the NP, the major constituents of the
system [19]. The concept is defined by taking into account
both the characteristics of the population who will use the
system (tremor patients, typically of advanced age), and the
functional impact of tremor.
A. Concept Design of the Cognitive Human-Robot Interface
The goal of our NP is to provide a novel alternative
for functional compensation of tremor during daily living.
Hence, the NP is designed to actuate only when tremor may
impede or hamper the realization of a voluntary movement.
On the contrary, if tremor appears in a non functional context,
like, for example, rest tremor in PD, the NP should not
actuate. Further, the NP should be ideally triggered by the
natural processes of the central nervous system, and not
by “artificial” commands (or mental states [20]) that imply
a learning process by the user, and thus are cognitively
demanding. The use of natural commands has a strong
positive impact on usability, and would permit expanding
the use of the NP to the elder, and to people with mild
cognitive impairment, as it is the case of many tremor
patients [21]. These ideas are put together as a series of
functional requirements for the cHRI, which is in charge of
decoding user commands, and generating information to the
pHRI that controls the NP [19]. These requirements are:
1) The NP must actuate only when it is needed, i.e. when
the user wants to perform a volitional movement during
which tremor may be cause of disability.
2) The interface must be natural, avoiding the perfor-
mance of demanding cognitive processes.
3) The response of the interface must be fast, because
some ADLs typically have short duration.
4) Tremor, in the presence of concomitant voluntary
movement, needs to be accurately parameterized, ide-
ally with no delay, in order to drive the controller that
modulates neurostimulation.
The first two requirements imply that certain neural pro-
cesses need to be detected and characterized, and impose the
need of technologies that record the cortical structures that
participate in movement planning and control. The third and
fourth requirement, on the other hand, are also related to the
signal processing techniques employed, and constrain their
response time and accuracy respectively.
B. Concept Design of the Physical Human-Robot Interface
Upper limb tremor typically appears at the distal segments,
being most prominent at the hands and the forearm for ET
[22], and at the hands, commonly expressed as a “pill rolling”
pattern (pronation-supination), for PD [23]. Functional anal-
ysis shows that wrist flexion-extension, forearm pronation-
supination and elbow flexion-extension have the largest
impact on disability [24], as expected from the segments
exhibiting the most severe tremor. Moreover, given that the
NP is envisioned as a functional compensation system, it has
to suppress the tremor while not affecting the performance
of volitional movements. Finally, for the prototype to be
usable, neurostimulation has to be delivered in such a way
that discomfort is avoided, and the appearance of muscle
fatigue and accommodation delayed to the maximum. These
ideas yield a series of requirements for the pHRI:
1) Tremor has to be attenuated at the degrees of freedom
(DoF) in which it impairs the performance of ADLs.
2) The NP has to reduce tremor amplitude without affect-
ing concomitant voluntary movement.
3) Drawbacks arising from neurostimulation, namely dis-
comfort, appearance of muscle fatigue, and accommo-
dation need to be avoided or minimized.
The first requirement is immediately met if the NP is
capable of selectively activating the major pair of antagonists
that control the movements defined above. Achievement of
the second requirement needs for: i) the development of
a control strategy that attenuates tremor but not voluntary
movement, and ii) the selective activation of the targeted
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to move
cHRI
controller
controller
pHRI
tremor 
onset &
parameters
tremor 
onset &
parameters
EEG hd-sEMG
MEMS
sensor
neurostim.
system
Fig. 1. Concept design of the NP, showing both the cHRI and the pHRI.
DoF(s), without affecting muscles that control other move-
ments. The issues included in the third requirement are
related to electrode placement, neurostimulation parameters,
and their modulation.
C. Implementation of the Neuroprosthesis
The cHRI implemented consisted in a multimodal inter-
face comprising electroencephalography (EEG), surface elec-
tromyography (sEMG), and MEMS inertial sensors (solid
state gyroscopes), and assessed the concurrent generation,
transmission and execution of voluntary and tremulous
movements (see Fig. 1). This interface triggered the NP
when the user intended to perform a voluntary movement (as
detected from the analysis of event related desynchronization
with EEG [25]), and started the neurostimulation when
volitional muscle activity was detected concurrently with the
tremor (with sEMG). Then, it modulated the neurostimula-
tion based on tremor parameters extracted with the solid
state gyroscopes. This implementation met all the design
criteria defined, namely, it was triggered in a natural manner
to the user only when tremor appeared during a voluntary
movement, and attained high accuracy and reliability with
short delay (see [26] for details). However, due to the current
lack of usablity of some of the technologies implemented
(mainly the EEG), we decided to use a simplified cHRI
that only included solid state gyroscopes for the validation.
Thus, tremor parameters were estimated using the algorithm
presented in [14], and fed into the controller at the pHRI.
Regarding the design of the pHRI, the NP stimulated the
major pair of antagonists controlling wrist flexion-extension
and elbow flexion-extention. However, muscles producing
pronation are very deep [27], which renders accurate control
of forearm pronation-supination with transcutaneous elec-
trodes extremely complicated, and was thus disregarded. The
last two design criteria were incorporated in the controller
as follows. The control strategy we implemented relied on
muscle co-contraction as a means to lower the natural cut
off frequency of muscles (∼2–3 Hz [28]), and attenuate
the tremor. This approach inherently minimized the impact
on voluntary movement, because it has lower frequency
than tremor [14]. Furthermore, the controller modulated
continuously the amplitude of the current injected according
to tremor parameters derived with the cHRI, therefore min-
imizing current density. This delayed to the maximum the
appearance of muscle fatigue and the effects of accommoda-
tion to neurostimulation, and avoided discomfort. Thus, the
pHRI fully met two of the three criteria previously defined,
and one partly. Details on the controller are given in [18].
III. METHODS
Twelve patients (2 female, mean ± SD age: 54.1 ± 17.5
years, from 22 to 70) suffering from PD (n = 3) or ET (n = 9)
participated in the study. Tremor severity ranged from very
mild to severe (from 2 to 30 according to Fahn-Tolosa-Marin
score; rating only including the most affected limb). PD
patients did not interrupt their medication for the recordings;
ET patients were off medication for 24 h. All signed a written
informed consent. The protocol was approved by the Ethical
Committee at Universidad Polite´cnica de Valencia.
The NP comprised 4 solid state gyroscopes (Technaid S.L.,
Madrid, Spain), and 2 multichannel monopolar stimulators
(UNA Systems, Belgrade, Serbia). It was implemented as a
series of textile substrates that integrated the gyroscopes, and
were placed over the stimulation electrodes. Patients wore the
NP at the limb exhibiting the most severe tremor. Gyroscope
placement followed [29]. Stimulation electrodes were located
over the flexor carpi radialis, extensor carpi ulnaris, biceps
(long head), and triceps (lateral head); common electrodes
were placed at the wrist and the olecranon respectively.
Each patient performed a number of repetitions of two
types of trials (named CO and NO). CO trials were divided
into two parts: the first without co-contraction (NP off) and
the second with co-contraction (NP on). With this design, we
circumvented the possible influence of tremor fluctuations
among trials. During the NO trials, the NP was never
activated; the aim was to assess the natural variation of the
tremor, and compare it with that caused by the NP in the CO
trials. This way, we avoided that intra-trial tremor variations
had an effect on the results. Trial duration was 30–35 s. The
order of both types was randomized using latin squares. In
total, each patient performed between 6 and 12 repetitions.
When necessary, strategies to enhance the tremor were used
(e.g. [30], [31]). During each trial, the patients performed
the clinical task that made their tremor more evident. The
task was chosen among the finger to nose test, the finger to
finger test, resting the arm on the lap, and keeping both arms
outstretched [22]. Controller gains and maximum stimulation
amplitudes were identified manually before the recordings.
Tremor attenuation was computed as the ratio Ratt of the
integral of the power spectral density (p.s.d., 1 s windows,
with zero padding) of the tremor during the part of the trial
with neurostimulation, to the same variable without it (for
CO trials) [13]. We also calculated Ratt for the NO trials
to investigate if the NP achieved a real tremor reduction
(one-way ANOVA between the log-transformed CO and NO
datasets). We present results only for the wrist, since many
patients did not present persistent elbow tremor.
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Fig. 2. Example of tremor suppression with the NP for an ET patient. Top
plot: a small window of the data in the time domain; bottom plot: compares
the p.s.d. without and with co-contraction in the entire trial.
TABLE I
EFFECT OF THE NP ON TREMOR AMPLITUDE.
Pat. Etiol. Task Freq. Ampl. NP Off Ampl. NP On
(Hz) (rad2s−3) (rad2s−3)
01 ET PO 4.24 111.60 ± 185.03 34.06 ± 26.59
02 PD PO,RE 3.51 65.42 ± 41.31 35.80 ± 55.27
03 ET PO,FN 5.11 15.68 ± 8.01 10.51 ± 4.10
04 PD RE 4.81 0.80 ± 0.52 0.51 ± 0.23
05 ET PO,RE 4.50 24.34 ± 42.86 2.37 ± 2.74
06 ET PO 8.08 0.62 ± 0.09 0.21 ± 0.06
07 ET PO 6.25 3.05 ± 2.76 1.08 ± 0.74
08 ET PO 8.38 0.22 ± 0.05 0.17 ± 0.15
09 ET PO 8.37 0.11 ± 0.08 0.01 ± 0.01
10 ET FN 5.60 0.19 ± 0.08 0.12 ± 0.03
11 PD PO 5.46 0.15 0.13
12 ET PO 9.27 0.03 ± 0.01 0.02 ± 0.01
IV. RESULTS
Fig. 2 presents a typical example of the performance of the
NP, showing how the amplitude of the tremor was reduced
after neurostimulation started. The data in the frequency do-
main illustrate that consistent reduction was obtained during
the whole trial. Table I compares, for all patients and CO
trials performed by each of them, the mean ± SD of tremor
amplitude in the ensemble of periods without (NP Off) and
with (NP On) co-contraction. Amplitude was quantified as
the integral of the p.s.d.; tremor frequency was computed as
the mean value in the absence of neurostimulation.
By grouping all trials with NP-driven tremor suppression
(CO trials), we found that tremor amplitude was notably
reduced (Ratt = 52.33 ± 25.48 %) in 89.4 % of them (42 out
of 47). This effect was statistically significant (p < 0.001,
one-way ANOVA, see Fig. 3). The experimental design of
the study, in which we compared the ratio Ratt between the
two periods of CO and NO trials, ensured that attenuation
was not a natural effect of the tremor, but caused by the NP.
Our data suggested that more severe tremors were attenu-
ated to a greater extent (e.g., tremor attenuation in trials with
greatest amplitude before co-contraction was Ratt = 22.8 ±
21.3 %), but the difference was not statistically significant (p
= 0.083, Mann-Whitney test). A pooled analysis of tremor
frequency without (NO trials) and with co-contraction (CO
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Fig. 3. Comparison of the variation of tremor amplitude within a trial, as
measured by Ratt, in the pooled datasets of trials without co-contraction
(NO) and with co-contraction (CO). Each circle (◦) represents a single trial
in either condition. The box plots show the median (central mark), the
first and third quartiles (upper and lower edges of the box), 1.5 times the
interquartile range (whiskers), and the outsiders (+).
trials) demonstrated that the NP did not alter it (p = 0.808,
one-way ANOVA), as expected from the central origin of ET
and PD [2]. Tremor was not attenuated in 5 trials: i) in 3 of
them two patients exhibited a tremor much milder than dur-
ing calibration, and the NP did not elicit a contraction large
enough because gains were underestimated, ii) in another, the
patient’s tremor was more severe than in previous trials, and
the maximum stimulation amplitude limited too much the
contraction level, and iii) in the last trial the patient exhibited
accommodation to neurostimulation [32]. Adequate selection
of controller gains and maximum stimulation amplitudes may
have avoided these issues [18].
V. CONCLUSIONS
This paper provided a series of requirements that a wear-
able NP for functional compensation of tremor should meet.
Based on them, we designed and implemented a prototype
that was tested on a representative group of patients. The
validation, which is presented here, demonstrates that the
NP attenuated the tremor significantly and systematically
in all the subjects, independently from its aetiology and
characteristics, and encourages the functional evaluation of
the system in a large cohort of patients.
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